Drug Channels

OCTOBER 23, 2023

With regulation and policy changes, specifically surrounding the DCSCA, IRA and serialization, the loss of exclusivity wave, adoption of low-WAC products affecting GTN and the rise of alternative distribution models, there has never been a more important time for industry to unite. Why should you attend this pivotal event?

Pharmacy 75

Pharmacy Biosimilars Marketing Production 75

The Pharma Data

SEPTEMBER 15, 2020

Regulation in biotech can be both a barrier and a solution for innovating the drug discovery process as the pharma industry shifts from blockbuster products toward new individualized forms of medicine. Download Your Copy. Balance risk and innovation in regulation using new digital-therapy products. Add bookmark.

Regulations 52

Regulations Production Therapies Treatment 52

Agency IQ

AUGUST 9, 2024

Commission proposes exemptions to UV-328 ban under POPs Regulation The European Commission plans to implement exemptions introduced under the Stockholm Convention’s 2023 ban of UV-328, an ultraviolet-light absorbing persistent organic pollutant (POP). UV-328 is used in a wide range of applications as a UV absorber and stabilizer.

Regulations 40

Regulations Production International Marketing 40

PPD

FEBRUARY 10, 2025

By harnessing the full range of innovative technologies and taking advantage of an FSP partners extensive skills and experience, sponsors are able to bring their therapies to market more quickly and within budget even in the face of complicated global regulations and widely fluctuating workloads.

Clinical Trials 52

Clinical Trials Trials Clinical Research Research 52

The Pharma Data

NOVEMBER 26, 2020

27, 2020 /PRNewswire/ — Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care. STOCKHOLM , Nov.

Marketing 40

Marketing Drugs Treatment Regulations 40

The Pharma Data

OCTOBER 27, 2020

FDA Investigational New Drug application to test Ortho-R, our lead Chitosan-PRP hybrid drug/biologic implant combination product, for rotator cuff tear repair in patients” The OTCQB Venture Market is the premiere marketplace for early stage and developing U.S. View original content to download multimedia: [link].

Marketing 40

Marketing Clinical Trials FDA International 40

The Pharma Data

SEPTEMBER 9, 2020

Download Your Copy. We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts, online learning opportunities and agree to our User Agreement. . Download Your Copy.

Production 52

Production Laboratories Compliance Government 52

PPD

AUGUST 16, 2023

Fortunately, leading global regulators have launched key initiatives. Study sponsors need quality results as quickly as possible to maximize profit-generation opportunities in the market. DOWNLOAD THE FULL DCT SITES SURVEY The post Emerging Trends in Clinical Trial Design appeared first on PPD Inc.

Clinical Trials 98

Clinical Trials Trials Clinical Research FDA 98

The Pharma Data

JANUARY 25, 2021

Maypharm is focusing on outstanding pharmaceutical products to provide superior botulinum toxin product with an up-to-date technological advantage and elaborated advanced manufacturing quality system and sophisticated equipment to meet the GMP requirements of the Agency’s CGMP regulations. For more information visit www.maypharm.net.

Production 52

Production Clinical Trials Marketing Regulations 52

H1 Blog

NOVEMBER 15, 2023

But in today’s highly regulated environment, it is more important than ever to make sure that HCP engagement plans are compliant with anti-kickback laws. However, with strict regulations surrounding interactions between industry and healthcare professionals, compliance must be at the forefront of any KOL engagement plan.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Drug Channels

SEPTEMBER 3, 2024

Download the brochure. The Healthcare Innovation Company's Value-Based Care Summit In-Person Event | October 28 - 29, 2024 in Washington, DC Use promo code VBCDC to save $100. Register Today.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Government Regulations 52

Perficient: Drug Development

FEBRUARY 5, 2024

Adhering to accessibility standards ensures that public spaces and services comply with regulations, reinforcing the legal imperative of inclusivity. Market Appeal Products and services that embody Equitable Use principles appeal to a broader market.

Production 52

Production Marketing Compliance Regulations 52

The Pharma Data

NOVEMBER 4, 2020

The aim is to sign 1-2 new license agreements per year, with focus on orthopedic and dental implants, as well as different types of products for the urinary tract, blood stream and airways for the global market. We now have a broader base and better market coverage in Europe , the Middle East , India , Southeast Asia and China.

Licensing 52

Licensing Licensing Production Marketing 52

The Pharma Data

DECEMBER 21, 2020

” Kaiser Permanente’s elimination of member out-of-pocket costs applies to all fully insured benefit plans, in all markets, unless prohibited or modified by law or regulation. View original content to download multimedia: [link]. Media Contact: Marc Brown marc.t.brown@kp.org 510-407-2592. Source link.

Virus 52

Virus Clinical Research Treatment Disease 52

Agency IQ

JUNE 7, 2024

Almost 10 years late, the new framework’s arrival will represent significant changes in the regulation of these pesticide substances. Active substances that have been approved for use in the EU are listed in the Annex of Regulation (EU) No 540/2011; currently, approximately 450 entries are listed.

Regulations 40

Regulations Animal Testing Production Marketing 40

The Pharma Data

OCTOBER 25, 2020

. About Santen As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices. View original content to download multimedia: [link]. Contact. .

Treatment 52

Treatment FDA Pharmaceuticals Clinical Trials 52

The Pharma Data

DECEMBER 27, 2020

. This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The following files are available for download: View original content: [link]. This information was brought to you by Cision [link].

Treatment 52

Treatment Therapies Regulations Marketing 52

Perficient: Drug Development

MAY 16, 2024

Legal Obligations : Many countries have laws and regulations mandating accessibility standards for digital content and technology. Accessible design expands market reach, enhances customer satisfaction, and fosters brand loyalty. It promotes autonomy, freedom, and a sense of belonging in an increasingly digital society. What is next?

Production 52

Production Marketing Compliance Engineering 52

The Pharma Data

OCTOBER 25, 2020

” This disclosure contains information that RhoVac is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The following files are available for download: View original content: [link]. This information was brought to you by Cision [link]. SOURCE RhoVac. Source link.

Regulations 40

Regulations Disease Marketing 40

Drug Channels

AUGUST 14, 2021

In such a fluid year for medication access and affordability, join influential stakeholders as they innovate on copay program design and operations, identify key trends in market access, patient affordability and the future of the drug pricing and analyze the impact of cost sharing on out of pocket costs and high deductible health plans.

Government 40

Government Regulations Therapies Drugs 40

The Pharma Data

NOVEMBER 1, 2020

This is information that Hansa Biopharma AB is obliged to make public pursuant to the EU Market Abuse Regulation. The following files are available for download: View original content: [link]. This information was brought to you by Cision [link]. SOURCE Hansa Biopharma AB.

Regulations 40

Regulations Marketing 40

Perficient: Drug Development

SEPTEMBER 27, 2023

including phone calls, app downloads, and in-app purchases, among others. In summary, Enhanced Conversions addresses the challenges posed by privacy regulations and limited access to third-party information. With Enhanced Conversions, advertisers can capture and measure various types of conversions beyond standard website conversions.

Regulations 52

Regulations Compliance Marketing 52

The Pharma Data

OCTOBER 27, 2020

ASP5354 is an investigational compound discovered by Mie University and Nagoya University, with Astellas acquiring exclusive development and marketing rights worldwide. View original content to download multimedia: [link]. SOURCE Astellas. Source link. Source link.

FDA 52

FDA Pharmaceuticals Production Clinical Trials 52

The Pharma Data

DECEMBER 15, 2020

This disclosure contains information that Lipidor is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The following files are available for download: View original content: [link]. The information was submitted for publication, through the agency of the contact person, on 16-12-2020 08:15 CET.

Production 52

Production Laboratories Licensing Licensing 52

The Pharma Data

JANUARY 31, 2021

An issue of SEK denominated senior unsecured callable floating rate bonds in the amount up to SEK 500 million , under a framework of SEK 1,000 million and with a tenor of four years (the “New Bonds”) may follow, subject to, inter alia, market conditions. CONTACT: This information was brought to you by Cision [link].

Production 40

Production Marketing Regulations Therapies 40

Agency IQ

NOVEMBER 20, 2023

Both labels would provide the framework for the consistent placement and order of the regulated portions of pesticide label information, with the digital label organizing the contents as data. Additional redundancies in multiple iterations of label submissions, marketing claims, and additional languages also create review lag time.

Regulations 40

Regulations Production International Compliance 40

Perficient: Drug Development

AUGUST 20, 2023

This post is an overview of a composable Sitecore Send offering – an email marketing automation solution with no code campaign automation. It aims to be a global leader in the market automation space, with accolades for usability and customer satisfaction. Later, you can also import a JSON file back into the editor.

Marketing 52

Marketing Regulations Production International 52

Perficient: Drug Development

MAY 9, 2024

Benefits for Students UDL provides students with greater autonomy and control over their learning experiences, promoting self-regulation and independence. UDL encourages educators to reflect on their teaching practices and continuously strive for improvement, leading to enhanced student outcomes and satisfaction.

Production 52

Production Regulations Marketing 52

The Pharma Data

NOVEMBER 26, 2020

This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. The following files are available for download: View original content: [link]. Finnish time. About Nanoform.

Small Molecule 52

Small Molecule Clinical Trials Marketing Pharmaceuticals 52

Agency IQ

AUGUST 23, 2024

applications) on biopharmaceutical products to regulators for review and marketing authorization throughout the region via three routes. First, sponsors can opt to pursue marketing authorization in an EU member state by submitting their dossier to that state’s health authority (i.e., the “national competent authority,” or NCA).

Clinical Trials 40

Clinical Trials Trials Regulations Production 40

Agency IQ

JUNE 28, 2024

New guidance provides definition for orphan device, offers alternative trial designs New guidance from the European Commission outlines alternatives for full pre-market clinical trials for orphan devices, defined by the Commission for the first time. Sections 5 – 9 are labeled as Part A and cover clinical evaluation considerations.

Trials 40

Trials Marketing Clinical Trials Disease 40

The Pharma Data

JANUARY 10, 2021

Download the slideshow of meetings on the Company website, in the Documentation section dedicated to investors: www.valbiotis.com/en/documents/. ABOUT VALBIOTIS VALBIOTIS is a Research & Development company committed to scientific innovation for preventing and combating metabolic diseases in response to unmet medical needs.

International 40

International Pharmaceutical Companies Disease Licensing 40

Perficient: Drug Development

OCTOBER 16, 2023

Sensory Support : Sensory integration apps and devices offer assistance with sensory processing and self-regulation. Navigation Assistance : GPS and location-based apps help individuals with cognitive disabilities find their way and enhance independence.

Production 52

Production Regulations Disease Marketing 52

PPD

OCTOBER 2, 2024

To support these functions, PPD™ Functional Service Partnership (FSP) Clinical Operations solutions harness the full range of innovative technologies, applying extensive skill and expertise to empower our customers to bring therapies to market quickly and within budget.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Research Trials 52

The Pharma Data

NOVEMBER 24, 2020

” This disclosure contains information that RhoVac is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The following files are available for download: View original content: [link]. This information was brought to you by Cision [link]. SOURCE RhoVac. Source link.

FDA 40

FDA Clinical Trials Drugs Therapies 40

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. Nanoform’s shares are listed on the Premier-segment of Nasdaq First North Growth Market in Helsinki (ticker: NANOFH) and Stockholm (ticker: NANOFS). . +46 7686 650 11. 2 Proof of Concept.

Clinical Trials 40

Clinical Trials Trials Production Regulations 40

The Pharma Data

JANUARY 13, 2021

A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded at the link below. Other statements regarding future product developments, and markets, including with respect to specific indications, and any other statements which are other than statements of historical fact. Source link.

Clinical Trials 52

Clinical Trials Trials Treatment Pharmaceuticals 52